|Reference : What is new in anemia treatment in CKD since 2010?|
|Scientific congresses and symposiums : Unpublished conference|
|Human health sciences : Urology & nephrology|
|What is new in anemia treatment in CKD since 2010?|
|Krzesinski, Jean-Marie [Université de Liège - ULg > Département des sciences cliniques > Néphrologie >]|
|5ème symposium de dialyse belge|
|du 17 avril au 19 avril 2012|
|Fresenius Medical Care|
|[en] anemia ; treatment ; CKD ; Anémie ; traitement ; IRC|
|[en] •Partial correction (Hb in the range of 10-11.5 g/dL) of CKD-related anemia appears a safer strategy during the last 5y. So recommendation is to start ESA only when Hb <10 and to avoid too high ESA dose (CE DOSE study ongoing in HD)!
•Identify resistant patients and try to improve it.
•Importance of adequate iron management and of hepcidin role in the all-mortality risk in CKD.
Newer strategies for correcting anemia are currently explored
|File(s) associated to this reference|
There are no fulltext file associated with this reference.
All documents in ORBi are protected by a user license.